OrbiMed’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $11.8M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $14.2M | Buy |
|
|||||
|
2020
Q3 | $4.41M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $4.11M | Hold |
|
|||||
|
2019
Q3 | $3.46M | Sell |
|
|||||
|
2019
Q2 | $2.72M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $65.4M | Buy |
|
|||||
|
2018
Q1 | $75.1M | Buy |
|
|||||
|
2017
Q4 | $25.6M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $40.2M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $39.2M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $3.37M | Sell |
|
|||||
|
2013
Q3 | $8.57M | Sell |
|
|||||
|
2013
Q2 | $23.5M | Buy |
|